Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma

• Main Authors: Albert Jang (Author), Jake N. Lichterman (Author), Jeffrey Y. Zhong (Author), Jonathan E. Shoag (Author), Jorge A. Garcia (Author), Tian Zhang (Author), Pedro C. Barata (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTRenal cell carcinoma (RCC), especially clear cell RCC, is generally considered an immunotherapy-responsive cancer. Recently, the prognosis for patients with locally advanced and metastatic RCC has significantly improved with the regulatory approvals of anti-PD-1/PD-L1/CTLA-4 immune checkpoin...